ANROVSLABT• 6 Months (Normalized)
ANRO vs LABT (Alto Neuroscience Inc. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Apr 3 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $27.5
+%
Alto Neuroscience Inc.
Normalized Baseline0.00%
LABT Performance $0.99
-98.86%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ANRO LEADS
+98.86 pts
ANRO outperforming by 98.86 percentage points
ANROLABT
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | ANRO Price | ANRO Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $0.99 | -98.86% | - | |
| Sep 28, 2026 | $- | $1.15 | -98.67% | - | |
| Sep 25, 2026 | $- | $1.67 | -98.07% | - | |
| Sep 24, 2026 | $- | $1.83 | -97.88% | - | |
| Sep 23, 2026 | $27.50 | +22.06% | $1.78 | -97.94% | +120.00% |
| Sep 22, 2026 | $30.78 | +36.62% | $1.99 | -97.70% | +134.32% |
| Sep 21, 2026 | $30.63 | +35.95% | $2.05 | -97.63% | +133.58% |
| Sep 18, 2026 | $30.27 | +34.35% | $1.99 | -97.70% | +132.05% |
| Sep 17, 2026 | $30.98 | +37.51% | $1.86 | -97.85% | +135.36% |
| Sep 16, 2026 | $30.00 | +33.16% | $2.09 | -97.58% | +130.74% |
| Sep 15, 2026 | $30.25 | +34.27% | $2.17 | -97.49% | +131.76% |
| Sep 14, 2026 | $31.68 | +40.61% | $2.12 | -97.55% | +138.16% |
| Sep 11, 2026 | $32.00 | +42.03% | $2.22 | -97.43% | +139.46% |
| Sep 10, 2026 | $31.68 | +40.61% | $2.05 | -97.63% | +138.24% |
| Sep 09, 2026 | $34.07 | +51.22% | $2.32 | -97.32% | +148.54% |
Page 1 of 9